Breast cancer is becoming one of the main lethal carcinomas in the recent era, and its
occurrence rate is increasing day by day. There are different breast cancer biomarkers, and …

Monoclonal antibodies (mAbs) are one of the most important classes of therapeutic proteins,
which are used to treat a wide number of diseases (eg, oncology, inflammation and …

The therapeutic use of Abs in cancer, autoimmunity, transplantation, and other fields is
among the major biopharmaceutical advances of the 20th century. Broader use of Ab-based …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected humans
worldwide for over a year now. Although various tests have been developed for the …

Monoclonal antibodies (mAbs) have been used in the development of immunotherapies that
target a variety of diseases, such as cancer, autoimmune diseases, and even viral infections; …

A structured approach to method development can help to ensure an analytical procedure is
robust across the lifecycle of its use. The analytical target profile (ATP), which describes the …

Bispecific antibodies have moved from being an academic curiosity with therapeutic promise
to reality, with two molecules being currently commercialized (Hemlibra® and Blincyto®) …

Paradoxically, trichothecenes have both immunosuppressive and immunostimulatory
effects. The underlying mechanisms have not been fully explored. Early studies show that …

When breast cells divide and multiply out of control, it is called breast cancer. Symptoms
include lump formation in the breast, a change in the texture or color of the breast, or a …

The present day modern formulation practices for drugs are based on newer tools and
techniques toward effective utilization. The methods of antibody formulations are to be …